Article

Review of Evidence-based Support for Pretreatment Imaging in Melanoma

This online activity provides oncology professionals a review of diagnosing and treating patients with melanoma.

Credits: 0.75

Fee: None

Expiration: April 15, 2010

Multimedia: None

Upon completing this activity, participants will be able to identify prognostic factors in patients with newly diagnosed melanoma; define the recommendations for pretreatment imaging from the National Comprehensive Cancer Network (NCCN) in patients with melanoma; describe the types of pretreatment imaging techniques used in patients with melanoma; describe imaging techniques for identifying regional lymph node metastases in patients with newly diagnosed melanoma; and describe biochemical tests used for assessing prognosis in patients with melanoma.

Click here to access this thrid-party website.

Related Videos
Linda Gillam, MD, MPH | Credit: Atlantic Health System
Uncovering the Role of COVID-19 in Rheumatic Disease, with Leonard Calabrese, DO
Linda Gillam, MD, MPH | Credit: Atlantic Health System
Jonathan Meyer, MD: Cognitive Gains, Dopamine-Free Schizophrenia Treatment with Xanomeline Trospium Chloride
Chelsie Monroe: Challenges Clinicians Should Consider When Prescribing Muscarinic Modulators for Schizophrenia
Allysa Saggese, NP | Credit: Weill Cornell Medicine
Zobair Younossi, MD, MPH | Credit: American College of Gastroenterology
© 2024 MJH Life Sciences

All rights reserved.